Skip to content

RDLNetworkEcosystem

Sign in Get started

© 2026 Raw Data Library. All rights reserved.

About FAQ Privacy Terms Contact

Monitoring antimalarial drug efficacy - Reply — Mayfong Mayxay (2004) | RDL Network

Home
Publications
Monitoring antimalarial drug efficacy - Reply

Shared by

Sir Nicholas White

University of Cambridge

Monitoring antimalarial drug efficacy - Reply

Clinical Infectious Diseases 38: 1193-1194

Article 2004 English

Authors

MM
Mayfong Mayxay
PN
Paul N. Newton
MK
Maniphone Khanthavong

Abstract

1 min read

No abstract is provided for this article.

Discussion(0)

Sign in to like and join the discussion.

No comments yet. Be the first to comment.

Publication Info

Year: 2004
Published: —
Language: English

Article Details

Journal Name: Clinical Infectious Diseases
Volume: 38
Pages: 1193-1194

Timeline

Created:June 19, 2026

Related publications

Antimalarial Drug Toxicity

Walter Taylor, Sir Nicholas White

Drug Safety

Risks associated with drug-eluting stents – Authors' reply

Joost Daemen, Peter Wenaweser, Stephan Windecker, Patrick W. Serruys

The Lancet

CAPTOPRIL OR FRUSEMIDE IN DRUG-RESISTANT HYPERTENSION - REPLY

A. B. Atkinson, J. J. Brown, A.F. Lever, Jis Robertson, Sir Nicholas White, B Rajagopalan, Hameed A. Yahaya, Ledingham Jgg.

The Lancet

Antimalarial drug resistance, Artemesinin-based combination therapy, and the contribution of modelling to elucidating policy choices

Shunmay Yeung, Wirichada Pongtavornpinyo, Ian M. Hastings, Anne Mills, Sir Nicholas White

Chapter in a book2007

Antimalarial Agents

Elizabeth A. Ashley, Sir Nicholas White